VMI
ETNB

VHCP Management III’s 89bio ETNB Stock Holding History

VHCP Management III’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$25.2M Buy
+958,765
New +$26.7M 5% 5

Other funds holding ETNB

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VHCP Management III's ETNB Position: Q4 2019 in Review

VHCP Management III opened a new position in 89bio (ETNB) in Q4 2019: 958,765 shares worth $25.2M. The stake represents 5% of the portfolio and ranks #5 among its holdings.

34 funds tracked by Wall St. Rank hold ETNB as of Q4 2019.

  • VHCP Management III held 958,765 shares of 89bio worth $25.2M as of Q4 2019.
  • 89bio was a new VHCP Management III position in Q4 2019.
  • 89bio made up 5% of VHCP Management III's portfolio in Q4 2019, its #5 holding.
  • 34 funds tracked by Wall St. Rank held 89bio as of Q4 2019.

Based on VHCP Management III's 13F filing for Q4 2019, filed 13 Feb 2020.